Stock Price Quote

ALEMBIC LTD.

NSE : ALEMBICLTDBSE : 506235ISIN CODE : INE426A01027Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE83.663.48 (+4.34 %)
PREV CLOSE ( ) 80.18
OPEN PRICE ( ) 80.19
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 82234
TODAY'S LOW / HIGH ( )80.19 84.20
52 WK LOW / HIGH ( )55.52 107.5
NSE83.453.1 (+3.86 %)
PREV CLOSE( ) 80.35
OPEN PRICE ( ) 80.95
BID PRICE (QTY) 83.45 (5)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1158434
TODAY'S LOW / HIGH( ) 80.90 84.40
52 WK LOW / HIGH ( )55.45 107.65
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-07 1907
Management Info
Chirayu Amin - Chairman Malika C Amin - Managing Director
Registered Office

Address Alembic Road,,,
Vadodara,
Gujarat-390003

Phone 0265-2280550 / 2280880

Email alembic.investors@alembic.co.in

Website www.alembiclimited.com

Registrars Details
Link Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
Listing : BSE, NSE, MCX

NEWS

27Feb Alembic informs about loss of share ce
Alembic has informed that it enclosed the intimation dated 27th February..
24Feb Alembic informs about loss of share ce
Alembic has informed that it enclosed the intimation dated 24th February..
22Feb Alembic informs about loss of share ce
Alembic has informed that it enclosed the intimation dated 22nd February..
14Feb Alembic submits unaudited financial re
Alembic has informed that it enclosed Consolidated and Standalone Unaudi..
16Jan Alembic informs about loss of share ce
Alembic has informed that it enclosed the intimation dated 16th January,..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit112.9792.7
Gross Profit 125.2 850
Operating Profit 153.51021.3
Net Sales 379.41231.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
peergroup  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
peergroup  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
peergroup  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
peergroup  1943.10 (3.26%)
M.Cap ( in Cr)32917.29

Shareholding Pattern

PROMOTERS 70.88%
NON-INSTITUTION 28.18%
FI/BANKS/INSURANCE 0.04%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Alembic Ltd.

Alembic Ltd. was incorporated in the year 1907. Its today's share price is 83.66. Its current market capitalisation stands at Rs 2148.24 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1231.58 Cr and Total Income of Rs.1872.71 Cr. The company's management includes Keval Thakkar, Girish Hirode, Abhijit Joshi, Rati Desai, Mayank Amin, Sameer Khera, CP Buch, Udit Amin, Malika C Amin, Chirayu Amin.

It is listed on the BSE with a BSE Code of 506235 , NSE with an NSE Symbol of ALEMBICLTD and ISIN of INE426A01027. It's Registered office is at Alembic Road,,Vadodara-390003, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are CNK & Associates LLP, K S Aiyer & Co., KS Aiyar & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.